Moritz Maas

8PUBLICATIONS
16CO-AUTHORS
Medical biotechnology diagnostics (incl. biosensors)Molecular targetsPredictive and prognostic markersLiquid biopsiesSurface water quality processes and contaminated sediment assessment
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 12, 2026
Closing the diagnostic gap in upper tract urothelial carcinoma: the emerging role of urinary multiplex biomarkers.

|Jun 25, 2026
Nectin-4 expression in clear cell renal cell carcinoma.

|Apr 13, 2024
PD-L1 Expression in High-Risk Non-Muscle-Invasive Bladder Cancer Is Influenced by Intravesical Bacillus Calmette-Guérin (BCG) Therapy.

Moritz Maas, Andreas Hilsendecker, Alexandra Pertoll

|Sep 08, 2023
A Protocol for Organoids from the Urine of Bladder Cancer Patients.

Simon Walz, Paul Pollehne, Ruizhi Geng

|May 24, 2023
Urine biomarkers in bladder cancer - current status and future perspectives.

Moritz Maas, Tilman Todenhöfer, Peter C Black

|Mar 29, 2023
Differential Expression and Clinical Relevance of C-X-C Motif Chemokine Receptor 4 (CXCR4) in Renal Cell Carcinomas, Benign Renal Tumors, and Metastases.

Moritz Maas, Aymone Kurcz, Jörg Hennenlotter

Pageof 2

Frequent Collaborators

4 joint publications

Arnulf Stenzl

3 joint publications

Steffen Rausch

2 joint publications

Simon Walz

2 joint publications

Niklas Harland